WAe001-A-1S

MB-/-#1

General

Cell Line

hPSCreg name WAe001-A-1S
Cite as:
WAe001-A-1S (RRID:CVCL_C9JQ)
Alternative name(s)
MB-/-#1
Cell line type Human embryonic stem cell (hESC)
Similar lines
WAe001-A
(WA01, H1)
WAe001-A-A
(H1X-10/H1.2-20)
WAe001-A-2B
(H1-NSD2-/-)
WAe001-A-B
(H1X-59/H1.2-6)
WAe001-A-C
(H1X-10/H1.3-62)
WAe001-A-D
(H1X-59/H1.3-68)
WAe001-A-E
(H1X-10/H1.4-4)
WAe001-A-F
(H1X-59/H1.4-5)
WAe001-A-86
(H1.139, H1.1-39)
WAe001-A-72
(H1-FTO-Knockout-13)
WAe001-A-31
(H1_RB1ex1_D6)
WAe001-A-32
(H1_RB1ex1_E9)
WAe001-A-87
(H1.213, H1.2-13)
WAe001-A-G
(H1X-10/H1.5-1)
WAe001-A-88
(H1.2-124, H1.2124)
WAe001-A-1N
(H1-FIS1-KO, WA01-FIS1-KO)
WAe001-A-89
(H1.3-64, H1.364)
WAe001-A-H
(H1X-59/H1.5-33)
WAe001-A-1O
(WA01-MYB-KO, H1-MYB-KO)
WAe001-A-77
(H1 RYBP-FLAG-HA KI)
WAe001-A-90
(H1.3-191, H1.3191)
WAe001-A-I
(H1.0-29/H1.1-13)
WAe001-A-41
(H1-RNF2-KO-1#)
WAe001-A-J
(H1.0-102/H1.1-34)
WAe001-A-42
(H1-RNF2-KO-2#)
WAe001-A-K
(H1.0-29/H1.2-31)
WAe001-A-1
(H1.1, WA01.1)
WAe001-A-L
(H1.0-102/H1.2-6)
WAe001-A-M
(H1.0-29/H1.3-22)
WAe001-A-N
(H1.0-102/H1.3-90)
WAe001-A-91
(H1.4-126, H1.4126)
WAe001-A-O
(H1.0-29/H1.4-14)
WAe001-A-92
(H1.4-143, H1.4143)
WAe001-A-P
(H1.0-102/H1.4-19)
WAe001-A-93
(H1.5-23, H1.523)
WAe001-A-78
(H1X10, H1X-10)
WAe001-A-94
(H1.528, H1.5-28)
WAe001-A-Q
(H1.0-29/H1.5-6)
WAe001-A-73
(H1-GATAD2B-KO-79#)
WAe001-A-R
(H1.0-102/H1.5-44)
WAe001-A-10
(H1_RB1ex3_G3)
WAe001-A-74
(H1-GATAD2B-KO-81#)
WAe001-A-S
(H1.1-17/H1.2-11)
WAe001-A-11
(H1_RB1ex3_G4)
WAe001-A-T
(H1.1-39/H1.2-9)
WAe001-A-U
(H1.1-17/H1.4-18)
Last update 13th March 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator King Abdullah International Medical Research Center (KAIMRC)
Owner King Abdullah International Medical Research Center (KAIMRC)
Distributors
Derivation country Saudi Arabia

External Databases

BioSamples SAMEA112769105
Cellosaurus CVCL_C9JQ
Wikidata Q123033807

General Information

Publications
* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity N/A

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes
XY, male Passage 45
Karyotyping method: G-Banding

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor
All cell lines of this donor's relatives

External Databases (Donor)

BioSamples SAMEA7767418

Ethics

Also have a look at the ethics information for the parental line WAe001-A .

hESC Derivation

The source cell information can be found in the parental cell line WAe001-A.

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ Plus
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
SOX2
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
GATA4
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Brachyury or TBXT
Yes
CDX2
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
PAX6
Yes
NESTIN or NES
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
XY, male
Passage number: 62
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Genetic modifications
Myoglobin (target)
Gene knock-out
CRISPR-associated (CRISPR/Cas) System
Genetic modifications not related to a disease
Myoglobin (target)
Gene knock-out
22q12.3
Sanger sequencing analysis showed 15 bp deletion NM_005368.3:c. [-2-13del15] in one allele and 8 bp deletion NM_005368.3:c. [-1-7del8] in the second allele.
CRISPR-associated (CRISPR/Cas) System